Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | AMAM | PVLA | ANIP | ||
| Company | Ambrx Biopharma Inc ADR | Palvella Therapeutics Inc | ANI Pharma Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.99 | 126.04 | 77.95 | ||
| High | 28.00 | 131.01 | 79.50 | ||
| Low | 27.98 | 125.92 | 77.77 | ||
| Latest | 28.00 | 127.78 | 77.70 | ||
| Change | +0.02 | +0.66 | -0.66 | ||
| % Change | +0.07% | +0.52% | -0.84% | ||
| Volume | 1,439,600 | 49,169 | 55,331 | ||
| 20-Day Average Volume | 1,545,680 | 277,313 | 347,376 | ||
| Previous Close | 27.98 | 127.12 | 78.36 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 27.86 | 119.85 | 75.57 | ||
| 20-Day Raw Stochastic | 94.23% | 68.57% | 65.78% | ||
| 20-Day Relative Strength | 80.97 | 55.59 | 52.95 | ||
| Weighted Alpha | +89.90 | +222.83 | +3.30 | ||
| Today's Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 56% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.21% since 02/28/24 | +5.37% since 04/06/26 | +1.14% since 04/06/26 | ||
| Low | 27.93 on 03/01/24 | 112.83 on 04/07/26 | 76.10 on 04/07/26 | ||
| High | 28.00 on 03/06/24 | 134.01 on 04/09/26 | 82.08 on 04/08/26 | ||
| 1-Month | |||||
| %Chg | +0.79% since 02/06/24 | +3.47% since 03/13/26 | +10.77% since 03/13/26 | ||
| Low | 27.51 on 02/20/24 | 108.63 on 03/30/26 | 70.39 on 03/16/26 | ||
| High | 28.03 on 02/26/24 | 134.40 on 03/16/26 | 82.08 on 04/08/26 | ||
| 3-Month | |||||
| %Chg | +132.75% since 12/06/23 | +21.98% since 01/13/26 | -5.10% since 01/13/26 | ||
| Low | 11.74 on 12/12/23 | 72.22 on 01/30/26 | 70.15 on 03/13/26 | ||
| High | 28.15 on 01/10/24 | 151.18 on 02/26/26 | 87.07 on 01/16/26 | ||
| 6-Month | |||||
| %Chg | +111.32% since 09/06/23 | +65.70% since 10/13/25 | -11.88% since 10/13/25 | ||
| Low | 6.55 on 10/23/23 | 68.96 on 10/28/25 | 70.15 on 03/13/26 | ||
| High | 28.15 on 01/10/24 | 151.18 on 02/26/26 | 97.00 on 10/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,768,200 | 1,819,596 | 1,756,360 | ||
| Shares Outstanding, K | 63,150 | 14,314 | 22,414 | ||
| Annual Sales | 7,400,000 | 0 | 883,370,000 | ||
| Annual Net Income | -78,000,000 | -41,720,000 | 78,340,000 | ||
| Last Quarter Sales | 1,120,000 | 0 | 247,060,000 | ||
| Last Quarter Net Income | -17,830,000 | -12,710,000 | 27,490,000 | ||
| 60-Month Beta | -1.92 | -0.21 | 0.44 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.05 on 08/09/23 | -1.08 on 03/31/26 | 2.33 on 02/27/26 | ||
| Latest Earnings Date | 04/04/24 | 05/21/26 | 05/08/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 12.58 | ||